Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) EBT Margin (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed EBT Margin for 16 consecutive years, with 10.18% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 859.0% to 10.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.31% through Dec 2025, up 1076.0% year-over-year, with the annual reading at 6.31% for FY2025, 1076.0% up from the prior year.
  • EBT Margin hit 10.18% in Q4 2025 for Cumberland Pharmaceuticals, up from 23.44% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 10.7% in Q1 2025 to a low of 67.11% in Q4 2023.
  • Historically, EBT Margin has averaged 14.46% across 5 years, with a median of 11.78% in 2024.
  • Biggest five-year swings in EBT Margin: tumbled -4068bps in 2023 and later soared 4834bps in 2024.
  • Year by year, EBT Margin stood at 52.59% in 2021, then surged by 50bps to 26.43% in 2022, then tumbled by -154bps to 67.11% in 2023, then skyrocketed by 72bps to 18.77% in 2024, then soared by 46bps to 10.18% in 2025.
  • Business Quant data shows EBT Margin for CPIX at 10.18% in Q4 2025, 23.44% in Q3 2025, and 6.73% in Q2 2025.